Technology
Health
Medical

Axogen

$21.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.01 (4.95%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Axogen and other stocks, options, ETFs, and crypto commission-free!

About

AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provide products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Read More Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.

Employees
297
Headquarters
Alachua, Florida
Founded
1977
Market Cap
793.97M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
587.17K
High Today
$21.78
Low Today
$20.79
Open Price
$21.30
Volume
272.25K
52 Week High
$56.85
52 Week Low
$14.13

Collections

Technology
Health
Medical
Education
US
North America
Female CEOs

News

Yahoo FinanceMar 20

Robbins Arroyo LLP: AxoGen, Inc. (AXGN) Misled Shareholders According to Class Action

SAN DIEGO & ALACHUA, Fla.--(BUSINESS WIRE)-- Shareholder rights law firm Robbins Arroyo LLP reminds shareholders that purchasers of AxoGen, Inc. (AXGN) filed a class action complaint against the company for alleged violations of the Securities Exchange Act of 1933 and Securities Act of 1934 pursuant to the company's November 2017 Secondary Public Offering ("SPO") and/or May 2018 SPO and/or between August 7, 2017 and December 18, 2018. AxoGen develops and markets surgical solutions for peripheral nerves. V...

78
Guru FocusMar 11

CLASS ACTION UPDATE for AXGN, MKL, VALE and VNDA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, March 11, 2019 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies.

119
Yahoo FinanceMar 11

FINAL DEADLINE - (AXGN) AxoGen, Inc. - Bronstein, Gewirtz & Grossman, LLC

NEW YORK, NY / ACCESSWIRE / March 11, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against AxoGen, Inc.

59

Earnings

-$0.11
-$0.09
-$0.07
-$0.05
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 29, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.